Abstract
It has been widely accepted that the age of women plays a fundamental role in fecundity, and age-related fertility decline has one of the most significant and detrimental effects on the success rate of infertility treatment. Therefore, treatment cycles of non-in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) treatment for infertile women of advanced aged have been limited due to their lack of efficacy, and they are often optimized, compared to IVF/ICSI treatment. Recent trends in infertility treatment apparently indicate that IVF/ICSI treatment, including egg donation, is frequently offered to aged women for first-line management, despite its heavy burden, but hasty IVF/ICSI treatment should be avoided, considering its socioeconomic problems. It is important to distinguish women who could conceive by non-IVF/ICSI treatment, although the optimization of non-IVF/ICSI treatment protocols remains poorly understood. This review focuses on extracting aged patients who have higher chance of conceiving with non-IVF/ICSI treatment and providing necessary and sufficient infertility treatment. After initial evaluation for fertility, including tubal factor, male factor, the presence of endometriosis and/or adenomyosis, and ovarian reserve, the outcomes of fertility treatment can be predicted to some extent in aged infertile women.
Similar content being viewed by others
Abbreviations
- AFC:
-
Antral follicle count
- AMH:
-
Anti-Müllerian hormone
- ART:
-
Assisted reproductive technology
- ASRM:
-
American society for reproductive medicine
- BMI:
-
Body mass index
- CC:
-
Clomiphene citrate
- CPR:
-
Cumulative pregnancy rate
- GS:
-
Gestational sac
- hMG:
-
Human menopausal gonadotropin
- ICSI:
-
Intracytoplasmic sperm injection
- IUI:
-
Intrauterine insemination
- IVF:
-
In vitro fertilization
- RCT:
-
Randomized controlled trial
- rFSH:
-
Recombinant FSH
- PR:
-
Pregnancy rates
References
ACOG Committee Opinion. Age-related fertility decline. Obstet Gynecol. 2008;112:409–11.
Dew JE, Don RA, Hughes GJ, Johnson TC, Steigrad SJ. The influence of advanced age on the outcome of assisted reproduction. J Assist Reprod Genet. 1998;15:210–4.
Ziebe S, Devroey P. Assisted reproductive technologies are an integrated part of national strategies addressing demographic and reproductive challenges. Hum Reprod Update. 2008;14:583–92.
Barton M, Walker K, Wiesner BP. Artificial insemination. Br Med J. 1945;1:40–3.
Frederick JL, Denker MS, Rojas A, Horta I, Stone SC, Asch RH, Balmaceda JP. Is there a role for ovarian stimulation and intra-uterine insemination after age 40? Hum Reprod. 1994;9:2284–6.
Lass A, Croucher C, Duffy S, Dawson K, Margara R, Winston RM. One thousand initiated cycles of in vitro fertilization in women > or = 40 years of age. Fertil Steril. 1998;70:1030–4.
Tsafrir A, Simon A, Revel A, Reubinoff B, Lewin A, Laufer N. Retrospective analysis of 1217 IVF cycles in women aged 40 years and older. Reprod Biomed Online. 2007;14:348–55.
Marinakis G, Nikolaou D. National survey of the current management of infertility in women aged 40 and over in the UK. J Obstet Gynaecol. 2012;32:375–8.
Corsan G, Trias A, Trout S, Kemmann E. Ovulation induction combined with intrauterine insemination in women 40 years of age and older: is it worthwhile? Hum Reprod. 1996;11:1109–12.
Japan.Society.of.Reproductive Medicine, http://plaza.umin.ac.jp/~jsog-art/, Accessed 3 7 2016.
Brandes M, van der Steen JO, Bokdam SB, Hamilton CJ, de Bruin JP, Nelen WL, Kremer JA. When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population, Hum Reprod. 2009;24:3127–35.
Speyer BE, Abramov B, Saab W, Doshi A, Sarna U, Harper JC, Serhal P. Factors influencing the outcome of intrauterine insemination (IUI): age, clinical variables and significant thresholds. J Obstet Gynaecol. 2013;33:697–700.
van der Westerlaken LA, Naaktgeboren N, Helmerhorst FM. Evaluation of pregnancy rates after intrauterine insemination according to indication, age, and sperm parameters. J Assist Reprod Genet. 1998;15:359–64.
Nuojua-Huttunen S, Tomas C, Bloigu R, Tuomivaara L, Martikainen H. Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Hum Reprod. 1999;14:698–703.
Isono W, Wada-Hiraike O, Shirane A, Fujimoto A, Osuga Y, Yano T, Taketani Y. Alternative strategies to in vitro fertilization/intracytoplasmic sperm injection treatment for aged infertile women. Reprod Med Biol. 2011;11:69–72.
Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH, Pyrzak R. Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate-intrauterine insemination. Fertil Steril. 2002;78:1088–95.
World Health Organization, WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction Cambridge University Press, 2010.
American Society for Reproductive Medicine, Endometriosis, A Guide for Patients https://www.asrm.org/BOOKLET_Endometriosis Accessed 3 7 2016.
Marcoux S, Maheux R, Berube S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis, N Engl J Med. 1997;337:217–22.
Ozkan S, Murk W, Arici A. Endometriosis and infertility: epidemiology and evidence-based treatments. Ann NY Acad Sci. 2008;1127:92–100.
Buyalos RP, Agarwal SK. Endometriosis-associated infertility. Curr Opin Obstet Gynecol. 2000;12:377–81.
Wu HM, Tzeng CR, Chen CH, Chen PH. Pelvic endometriosis with peritoneal fluid reduces pregnancy rates in women undergoing intrauterine insemination. Taiwan J Obstet Gynecol. 2013;52:512–5.
Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 1997;24:235–58.
Moradi M, Parker M, Sneddon A, Lopez V, Ellwood D. Impact of endometriosis on women’s lives: a qualitative study. BMC Womens Health. 2014;14:123.
Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol. 2002;186:409–15.
Huang JQ, Lathi RB, Lemyre M, Rodriguez HE, Nezhat CH, Nezhat C. Coexistence of endometriosis in women with symptomatic leiomyomas. Fertil Steril. 2010;94:720–3.
Hemmings R, Rivard M, Olive DL, Poliquin-Fleury J, Gagne D, Hugo P, Gosselin D. Evaluation of risk factors associated with endometriosis. Fertil Steril. 2004;81:1513–21.
Isono W, Wada-Hiraike O, Osuga Y, Yano T, Taketani Y. Diameter of dominant leiomyoma is a possible determinant to predict coexistent endometriosis. Eur J Obstet Gynecol Reprod Biol. 2012;162:87–90.
La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16:113–30.
Li HWR, Yeung WSB, Lau EYL, Ho PC, Ng EHY. Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination. Fertil Steril. 2010;94:2177–81.
La Marca A, Volpe A. Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? Clin Endocrinol. 2006;64:603–10.
Plosker SM, Jacobson W, Amato P. Predicting and optimizing success in an intra-uterine insemination programme. Hum Reprod. 1994;9:2014–21.
Dovey S, Sneeringer RM, Penzias AS. Clomiphene citrate and intrauterine insemination: analysis of more than 4100 cycles. Fertil Steril. 2008;90:2281–6.
Haebe J, Martin J, Tekepety F, Tummon I, Shepherd K. Success of intrauterine insemination in women aged 40–42 years. Fertil Steril. 2002;78:29–33.
Wyatt PR, Owolabi T, Meier C, Huang T. Age-specific risk of fetal loss observed in a second trimester serum screening population. Am J Obstet Gynecol. 2005;192:240–6.
Tsafrir A, Simon A, Margalioth EJ, Laufer N. What should be the first-line treatment for unexplained infertility in women over 40 years of age—ovulation induction and IUI, or IVF? Reprod Biomed Online. 2009;19(Suppl 4):4334.
Veltman-Verhulst SM, Cohlen BJ, Hughes E, Heineman MJ. Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev. 2012;9:CD001838.
Ferrara I, Balet R, Grudzinskas JG. Intrauterine insemination with frozen donor sperm. Pregnancy outcome in relation to age and ovarian stimulation regime, Hum Reprod. 2002;17:2320–4.
Belloc S, Cohen-Bacrie P, Benkhalifa M, Cohen-Bacrie M, De Mouzon J, Hazout A, Menezo Y. Effect of maternal and paternal age on pregnancy and miscarriage rates after intrauterine insemination. Reprod Biomed Online. 2008;17:392–7.
W.s. National Collaborating Centre for, H. Children’s, National Institute for Health and Clinical Excellence: Guidance, Fertility: Assessment and Treatment for People with Fertility Problems, Royal College of Obstetricians and Gynaecologists National Collaborating Centre for Women’s and Children’s Health, London, 2013.
Practice M. Committee of the American Society for Reproductive. Use of clomiphene citrate in infertile women: a committee opinion, Fertil Steril. 2013;100:341–8.
UpToDate, http://www.uptodate.com/contents/unexplained-infertility, Accessed 3 7 2016.
Acknowledgments
This report was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, The Mochida Memorial Foundation for Medical and Pharmaceutical Research, and The Nakatomi Foundation. This report was also supported by the Japan Society for Reproductive Medicine. The authors would like to thank American Journal Experts (http://www.aje.com) for the English language review.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
These authors declare that they have no conflicts of interest to disclose.
Human rights statements and informed consent
This article does not contain any studies with human subjects performed by any of the authors.
Animal rights
This article does not contain any studies with animal subjects performed by the any of the authors.
About this article
Cite this article
Akino, N., Isono, W. & Wada-Hiraike, O. Predicting suitable timing for artificial reproductive technology treatment in aged infertile women. Reprod Med Biol 15, 253–259 (2016). https://doi.org/10.1007/s12522-016-0241-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12522-016-0241-0